Guy Ofir - 26 Jul 2022 Form 4 Insider Report for Raphael Pharmaceutical Inc. (RAPH)

Reporting relationship: Chief Financial Officer, Director
Issuer ticker: RAPH
Reported as of: 26 Jul 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Mar 2023, 16:01:38 UTC
Prior SEC filing: 19 Nov 2021
Source filing: View source filing
Reporting owner signature: /s/ Guy Ofir

Key filing fact

Guy Ofir filed Form 4 for Raphael Pharmaceutical Inc. (RAPH) on 13 Mar 2023.

Key facts

This page summarizes Guy Ofir's Form 4 filing for Raphael Pharmaceutical Inc. (RAPH).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 13 Mar 2023, 16:01.

Change

Previous filing in this sequence was filed on 19 Nov 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RAPH transaction

Common Stock

Award

Transaction value: $0
Shares: +1,000,000
Change %: +375%
Price: $0.000000
Shares after: 1,266,455
Date: 26 Jul 2022
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RAPH transaction Derivative

Warrants to Purchase Common Stock

Award

Transaction value: $0
Shares: +1,000,000
Change %
Price: $0.000000
Shares after: 1,000,000
Date: 05 Dec 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,000,000
Exercise price: $1.00
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The warrants are exercisable immediately.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .